paperKB
coga / coga-kb
Help
Sign in

Chunk #4 — Results — GWAS of CUD and replication in an independt cohort from Iceland

Source
Genome-wide association study implicates CHRNA2 in cannabis use disorder.
Embedded
yes

Text

Data analysis was conducted using the Ricopili pipeline19, including stringent quality control of genotyped variants and individuals (Methods). Information about non-genotyped markers was obtained by imputation using the 1000 genomes phase 3 as reference panel. GWAS was performed using imputed marker dosages and an additive logistic regression model using the following covariates: relevant principal components to correct for confounders such as population stratification, presence of the major psychiatric disorders studied in iPSYCH and genotyping wave. Only markers with an imputation INFO score >0.7, minor allele frequency (maf) >0.01 and bi-allelic variants were retained, in total 8,971,679 genetic variants were included. We identified 26 genome-wide significant variants (P<5x10−8), located in a single locus on chromosome 8 (Figure 1 and 2). The index variant, rs56372821, showed an odds ratio of 0.73 (P=9.31x10−12) with respect to the minor allele A (Table 1, Figure 1 and 2). We found no signs of contributions from confounding factors like population stratification and cryptic relatedness to the inflation in the distribution of the test statistics (lambda=1.033; see quantile-quantile plot, Figure 1.B.) using LD score regression, since the